Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone + misoprostol versus misoprostol alone for second trimester missed miscarriage
PACTR202311776445720Recruiting
- Sponsor
- Rabiatu Musa Ahmed
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mifepristone and misoprostol in Pregnancy loss (2 arms), sponsored by Rabiatu Musa Ahmed. Primary endpoint: Treatment success. Started Nov 2022; status: recruiting.
02
Drugs
mifepristonemisoprostol
03
Conditions
Pregnancy loss
Beyond the preview
Go deeper on PACTR202311776445720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311776445720.